Literature DB >> 29345348

Roles of neutrophils in cancer growth and progression.

Maria Rosaria Galdiero1,2,3, Gilda Varricchi1,2,3, Stefania Loffredo1,2,3, Alberto Mantovani4,5, Gianni Marone1,2,3,6.   

Abstract

Chronic inflammation is a well-known tumor-enabling capacity, which allows nascent tumors to acquire all the hallmark capabilities, including the escape from immunosurveillance. Soluble and cellular inflammatory mediators constitute the complex network of the tumor microenvironment, in which tumors grow and with which constantly interact. Myeloid cells (e.g., tumor associated macrophages) are pivotal players of the tumor microenvironment and are characterized by plasticity, which consists of the ability to acquire distinct phenotypes in response to the microenvironment in which they reside. Neutrophils are emerging as important players of tumor microenvironment, given their heterogeneity and plasticity. Increasing evidence suggests a dual role for neutrophils in modulating tumor behavior and highlights the need for a reassessment of neutrophil functions in cancer initiation and progression. ©2017 Society for Leukocyte Biology.

Entities:  

Keywords:  cancer immunotherapy; cancer-related inflammation; predictive biomarker; prognostic factor; tumor-associated neutrophils

Mesh:

Year:  2017        PMID: 29345348     DOI: 10.1002/JLB.3MR0717-292R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  47 in total

Review 1.  Progressing from Recurring Tissue Injury to Genomic Instability: A New Mechanism of Neutrophil Pathogenesis.

Authors:  Triet M Bui; Ronen Sumagin
Journal:  DNA Cell Biol       Date:  2019-06-12       Impact factor: 3.311

2.  Innate immunity, inflammation and tumour progression: double-edged swords.

Authors:  A Mantovani; A Ponzetta; A Inforzato; S Jaillon
Journal:  J Intern Med       Date:  2019-03-14       Impact factor: 8.989

3.  Neutrophil elastase from myeloid cells promotes TSC2-null tumor growth.

Authors:  Manisha Taya; Maria de la Luz Garcia-Hernandez; Javier Rangel-Moreno; Briaunna Minor; Erin Gibbons; Stephen R Hammes
Journal:  Endocr Relat Cancer       Date:  2020-04       Impact factor: 5.678

Review 4.  Neutrophils: fast and furious-the nucleotide pathway.

Authors:  Dominique S Rubenich; Priscila O de Souza; Natalia Omizzollo; Gabriela S Lenz; Jean Sevigny; Elizandra Braganhol
Journal:  Purinergic Signal       Date:  2021-04-29       Impact factor: 3.765

5.  The presence of tumour-infiltrating neutrophils is an independent adverse prognostic feature in clear cell renal cell carcinoma.

Authors:  Basile Tessier-Cloutier; David Dw Twa; Mahsa Marzban; Jennifer Kalina; Hye-Jung E Chun; Nils Pavey; Zaidi Tanweer; Ruth L Katz; Julian J Lum; Davide Salina
Journal:  J Pathol Clin Res       Date:  2021-03-04

Review 6.  Getting TANned: How the tumor microenvironment drives neutrophil recruitment.

Authors:  Shuvasree SenGupta; Bhagawat C Subramanian; Carole A Parent
Journal:  J Leukoc Biol       Date:  2018-12-14       Impact factor: 6.011

7.  Targeting neutrophils as a novel therapeutic strategy after stroke.

Authors:  Chen Chen; Tingting Huang; Xiaozhu Zhai; Yezhi Ma; Lv Xie; Bingwei Lu; Yueman Zhang; Yan Li; Zengai Chen; Jiemin Yin; Peiying Li
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-10       Impact factor: 6.200

8.  Pivotal Role for Cxcr2 in Regulating Tumor-Associated Neutrophil in Breast Cancer.

Authors:  Colin Timaxian; Christoph F A Vogel; Charlotte Orcel; Diana Vetter; Camille Durochat; Clarisse Chinal; Phuong NGuyen; Marie-Laure Aknin; Françoise Mercier-Nomé; Martin Davy; Isabelle Raymond-Letron; Thi-Nhu-Ngoc Van; Sarah D Diermeier; Anastasia Godefroy; Magali Gary-Bobo; Franck Molina; Karl Balabanian; Gwendal Lazennec
Journal:  Cancers (Basel)       Date:  2021-05-25       Impact factor: 6.639

9.  Mature and Immature/Activated Cells Fractionation: Time for a Paradigm Shift in Differential Leucocyte Count Reporting?

Authors:  Rana Zeeshan Haider; Najeed Ahmed Khan; Eloisa Urrechaga; Tahir Sultan Shamsi
Journal:  Diagnostics (Basel)       Date:  2021-05-21

Review 10.  Chemotherapy: a double-edged sword in cancer treatment.

Authors:  Nafiseh Behranvand; Farzad Nasri; Reza Zolfaghari Emameh; Pouria Khani; Asieh Hosseini; Johan Garssen; Reza Falak
Journal:  Cancer Immunol Immunother       Date:  2021-08-05       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.